Search

Geron Corp

Закрыт

СекторЗдравоохранение

0.89 -5.32

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

0.87

Макс.

0.89

Ключевые показатели

By Trading Economics

Доход

-13M

-17M

Продажи

5.6M

57M

Прибыль на акцию

-0.02

Рентабельность продаж

-29.019

Сотрудники

258

EBITDA

-16M

-12M

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+347.43% upside

Дивиденды

By Acuity

Следующий отчет о доходах

4 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-82M

739M

Предыдущая цена открытия

6.21

Предыдущая цена закрытия

0.89

Geron Corp График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

30 окт. 2026 г., 20:03 UTC

Geron Corporation shares fell sharply, continuing a three-day decline and reaching a notable low, remaining well below their 20-day moving average.

29 окт. 2026 г., 20:07 UTC

News
Event

Wedbush maintains Outperform rating on Geron Corporation but lowers price target to $5; company discontinues Phase 3 IMpactMF trial for imetelstat.

28 окт. 2026 г., 20:02 UTC

Social Media
Event
Macro Event
News

Geron Corporation's stock declined sharply after discontinuing its Phase 3 IMpactMF trial for imetelstat due to unlikely success in meeting primary survival endpoints.

27 окт. 2026 г., 19:56 UTC

Geron Corporation is trading roughly flat, showing little change since Monday's close, and remains below its 20-day moving average.

26 окт. 2026 г., 20:06 UTC

Geron Corp's shares advanced, building on previous gains.

23 окт. 2026 г., 20:07 UTC

Geron Corp's shares are roughly flat, maintaining their position near Thursday's close amid broader market declines influenced by economic indicators and rising oil prices.

22 окт. 2026 г., 23:46 UTC

In after-market trading, Geron Corp is advancing sharply, with a cumulative return of 3.57% since Thursday's close.

21 окт. 2026 г., 23:41 UTC

Geron Corp shares advanced in after-market trading following Wednesday's close, briefly peaking before retracing slightly, but remain below their 20-day moving average.

20 окт. 2026 г., 20:08 UTC

Geron Corp shares are trading higher, maintaining momentum amid a broader market trend with significant gains observed in regular trading hours.

19 окт. 2026 г., 19:16 UTC

Geron Corp shares are advancing, reflecting broader market gains since Friday.

16 окт. 2026 г., 23:06 UTC

Geron Corp shares advanced modestly higher in after-market trading on Friday.

15 окт. 2026 г., 20:51 UTC

Geron Corp's shares advanced in after-market trading, rising notably from a low shortly after the close, reflecting stable performance within its one-month trading range.

14 окт. 2026 г., 23:11 UTC

Geron Corp shares advanced in after-market trading, remaining modestly higher since Wednesday's close, despite earlier pulling back from a session high.

13 окт. 2026 г., 20:01 UTC

Geron Corp shares are declining, remaining significantly below their 20-day moving average, with a cumulative return down since Monday's close.

12 окт. 2026 г., 22:16 UTC

Geron Corp shares are trading lower in after-market hours, retracing from an earlier session peak and remaining below their 20-day moving average.

9 окт. 2026 г., 19:45 UTC

Geron Corp shares are trading roughly flat, showing little change since Thursday's close and positioned below its 20-day moving average.

8 окт. 2026 г., 23:10 UTC

Geron Corp's shares advanced in after-market trading, moving higher from a low to a high since Thursday's close.

6 окт. 2026 г., 20:07 UTC

Geron Corp's shares fell sharply, reflecting broader market volatility, and remain significantly below their 20-day moving average amid a declining trend.

5 окт. 2026 г., 20:06 UTC

Geron Corp's shares are advancing, recovering from earlier declines and trading higher throughout the morning, though settling near the lower end of their one-month range.

1 окт. 2026 г., 20:07 UTC

Geron Corp shares fell sharply, continuing a downward trend and remaining below their 20-day moving average, near the lower end of their one-month range.

30 сент. 2026 г., 20:07 UTC

Geron Corp's shares are advancing, having closed higher since Tuesday, despite pulling back from an earlier session peak.

29 сент. 2026 г., 23:40 UTC

Geron Corp saw notable gains in after-market trading, reaching its highest point since Tuesday's close, though still below its 20-day moving average.

28 сент. 2026 г., 20:07 UTC

Geron Corp shares fell amid a broader market downturn, influenced by declines in major tech stocks and rising geopolitical tensions, reflecting increased volatility.

25 сент. 2026 г., 19:46 UTC

Geron Corp is trading higher, having peaked earlier before retracing, though it remains below its 20-day moving average amid broader market weakness.

24 сент. 2026 г., 20:07 UTC

Geron Corp is advancing during Thursday's trading session, having peaked in the mid-afternoon, although it remains below its 20-day moving average.

23 сент. 2026 г., 22:01 UTC

In after-market trading, Geron Corp has advanced notably, moving higher since Wednesday's close, despite being 11.49% below its 20-day moving average.

22 сент. 2026 г., 22:50 UTC

Geron Corp is advancing in after-market trading, recovering from earlier declines, though it remains below its 20-day moving average.

18 сент. 2026 г., 19:36 UTC

Geron Corp shares fell sharply, continuing a decline since Thursday and trading significantly below the 20-day moving average.

17 сент. 2026 г., 23:01 UTC

Geron Corp's shares rose in after-market trading, recovering from earlier losses to reach their highest level of the day since Thursday's close.

16 сент. 2026 г., 20:10 UTC

Geron Corp's shares fell sharply, continuing a decline from Tuesday and trading near the lower end of its one-month range.

Сравнение c конкурентами

Изменение цены

Geron Corp Прогноз

Целевая цена

By TipRanks

347.43% рост

Прогноз на 12 месяцев

Средняя 4 USD  347.43%

Максимум 5 USD

Минимум 3 USD

Основано на мнении 4 аналитиков Wall Street, спрогнозировавших целевые цены для Geron Corp на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

4 ratings

3

Покупка

1

Удержание

0

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
help-icon Live chat